Nutra Pharma Corporation announced that they have partnered with EuroAmerican IP, LLC to distribute their Over-the-Counter pain reliever, Nyloxin Topical Gel, through the Federal Supply Schedule. The successful addition to FSS will make the product available for purchase through the US - General Services Administration (GSA Advantage) website. Nyloxin is a safe, non-narcotic, and non-addictive Homeopathic pain reliever clinically proven to treat moderate to severe chronic pain while not impairing cognitive function. Nyloxin offers several benefits as pain relievers and anti-inflammatory agents. With increasing concern about consumers using opioid and acetaminophen-based pain relievers, Nyloxin offers an alternative that does not rely on opiates or non-steroidal anti-inflammatory drugs, otherwise known as NSAIDs, for their pain relieving effects. Nyloxin has a well-defined safety profile.